This increase in therapeutic activity was associated with increased CD4+ and CD8+ T cell and decreased Treg tumour infiltration, and an increase in the proportion of activated and effector memory and central memory T cells [76,77,78,86,88,91,92]. This evidence concerns the gene CD8A and neoplasm.